RT Journal Article
SR Electronic
T1 The Role of Vitamin D in The Age of COVID-19: A Systematic Review and Meta-Analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.05.20123554
DO 10.1101/2020.06.05.20123554
A1 Ghasemian, Roya
A1 Shamshirian, Amir
A1 Heydari, Keyvan
A1 Malekan, Mohammad
A1 Alizadeh-Navaei, Reza
A1 Ebrahimzadeh, Mohammad Ali
A1 Jafarpour, Hamed
A1 Shahmirzadi, Arash Rezaei
A1 Khodabandeh, Mehrdad
A1 Seyfari, Benyamin
A1 Motamedzadeh, Alireza
A1 Dadgostar, Ehsan
A1 Aalinezhad, Marzieh
A1 Sedaghat, Meghdad
A1 Behnamfar, Morteza
A1 Asadi, Anahita
A1 Zarandi, Bahman
A1 Razzaghi, Nazanin
A1 Naei, Vahid Yaghoubi
A1 Hessami, Amirhossein
A1 Azizi, Soheil
A1 Mohseni, Ali Reza
A1 Shamshirian, Danial
YR 2020
UL http://medrxiv.org/content/early/2020/10/26/2020.06.05.20123554.abstract
AB Background Evidence recommends that vitamin D might be a crucial supportive agent for the immune system, mainly in cytokine response regulation against COVID-19. Hence, we carried out a systematic review and meta-analysis in order to maximize the use of everything that exists about the role of vitamin D in the COVID-19.Methods A systematic search was performed in PubMed, Scopus, Embase, Cochrane Library, Web of Science, and Google Scholar (intitle) as well as preprint database of medRxiv, bioRxiv, Research Square, preprints.org, and search engine of ScienceDirect up to October 10, 2020. Studies focused on the role of vitamin D in confirmed COVID-19 patients were entered into the systematic review.Results Sixteen studies containing 4922 participants entered into the meta-analysis. The meta-analysis indicated that 48% of COVID-19 patients were suffering from vitamin D deficiency (95% CI, 29%-67%), and in 41% of patients, levels of vitamin D were insufficient (95% CI, 10%-82%). The serum 25-hydroxyvitamin D concentration was 18 ng/mL among all COVID-19 patients (95% CI, 13-24). Co-morbidities frequency in COVID-19 patients were as follows: 7.4% cancer, 27.1% chronic kidney disease, 30.4% cardiovascular diseases, 5.1% dementia, 14.5% depression/anxiety, 32.1% diabetes, 47.4% hypertension, 22.0% obesity and 17.5% respiratory diseases. Reported ethnic groups in studies were 1.0% Afro-Caribbean, 10.3% Asian, and 92.1% Caucasian.Conclusion This study found that the mean serum 25-hydroxyvitamin D level was low in all COVID-19 patients, and most of them were suffering from vitamin D deficiency/insufficiency. The Caucasian was the dominant ethnic group, and the most frequent co-morbidities in COVID-19 patients were hypertension, cardiovascular diseases, chronic kidney disease, diabetes, obesity, and respiratory diseases, which might be affected by vitamin D deficiency directly or indirectly.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNone.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A